Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Net Sales
9,203.54
7,896.00
6,658.25
5,985.81
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
9,203.54
7,896.00
6,658.25
5,985.81
Raw Material Cost
1,692.77
1,526.90
1,333.13
1,146.59
Purchase of Finished goods
2,397.25
1,883.24
1,332.48
1,047.25
(Increase) / Decrease In Stocks
-390.10
-263.53
-190.19
66.69
Employee Cost
1,552.20
1,446.29
1,292.08
1,117.33
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
2,086.86
1,828.73
1,661.03
1,426.77
Total Expenditure (Excl Depreciation)
7,338.99
6,421.62
5,428.53
4,804.63
Operating Profit (PBDIT) excl Other Income
1,864.55
1,474.38
1,229.72
1,181.18
Other Income
12.66
67.26
56.99
45.91
Operating Profit (PBDIT)
1,877.21
1,541.64
1,286.71
1,227.09
Interest
143.67
175.78
237.15
213.61
Exceptional Items
-31.35
-10.38
-9.93
-6.15
Gross Profit (PBDT)
1,702.19
1,355.48
1,039.63
1,007.33
Depreciation
415.05
384.13
312.41
260.12
Profit Before Tax
1,287.14
971.35
727.23
747.22
Tax
345.87
263.88
199.65
185.37
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
941.27
707.47
527.58
561.85
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
941.27
707.47
527.58
561.85
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
-16.91
-26.14
-29.39
-29.83
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
924.36
681.33
498.18
532.02
Equity Capital
189.57
189.48
181.15
180.85
Face Value
10.0
10.0
10.0
10.0
Reserves
4,760.44
4,256.70
2,771.13
2,320.27
Earnings per share (EPS)
48.76
35.96
27.5
29.42
Diluted Earnings per share
48.77
36.43
27.54
29.42
Operating Profit Margin (Excl OI)
20.26%
18.67%
18.47%
19.73%
Gross Profit Margin
18.49%
17.17%
15.61%
16.83%
PAT Margin
10.23%
8.96%
7.92%
9.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 16.56% vs 18.59% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 35.67% vs 36.76% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 26.46% vs 19.90% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -18.27% vs -25.88% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Emcure Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
9,203.54
3,917.99
5,285.55
134.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,203.54
3,917.99
5,285.55
134.90%
Raw Material Cost
1,692.77
820.03
872.74
106.43%
Purchase of Finished goods
2,397.25
496.95
1,900.30
382.39%
(Increase) / Decrease In Stocks
-390.10
-0.43
-389.67
-90,620.93%
Employee Cost
1,552.20
687.61
864.59
125.74%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
2,086.86
881.99
1,204.87
136.61%
Total Expenditure (Excl Depreciation)
7,338.99
2,886.15
4,452.84
154.28%
Operating Profit (PBDIT) excl Other Income
1,864.55
1,031.84
832.71
80.70%
Other Income
12.66
38.32
-25.66
-66.96%
Operating Profit (PBDIT)
1,877.21
1,070.16
807.05
75.41%
Interest
143.67
11.73
131.94
1,124.81%
Exceptional Items
-31.35
0.00
-31.35
Gross Profit (PBDT)
1,702.19
1,058.43
643.76
60.82%
Depreciation
415.05
171.04
244.01
142.66%
Profit Before Tax
1,287.14
887.39
399.75
45.05%
Tax
345.87
227.81
118.06
51.82%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
941.27
659.58
281.69
42.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
941.27
659.58
281.69
42.71%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-16.91
0.00
-16.91
Other related items
0.00
0.00
0.00
Consolidated Net Profit
924.36
659.58
264.78
40.14%
Equity Capital
189.57
15.57
174.00
1,117.53%
Face Value
10.00
1.00
0.00
Reserves
4,760.44
3,417.75
1,342.69
39.29%
Earnings per share (EPS)
48.76
42.36
6.40
15.11%
Diluted Earnings per share
48.77
41.56
7.21
17.35%
Operating Profit Margin (Excl OI)
20.26%
26.34%
0.00
-6.08%
Gross Profit Margin
18.49%
27.01%
0.00
-8.52%
PAT Margin
10.23%
16.83%
0.00
-6.60%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 9,203.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.56% vs 18.59% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 924.36 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 35.67% vs 36.76% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,864.55 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 26.46% vs 19.90% in Mar 2025
Annual - Interest
Interest 143.67 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -18.27% vs -25.88% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.26%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
